Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-068010
Filing Date
2026-06-12
Accepted
2026-06-12 08:00:31
Documents
2
Period of Report
2026-06-12

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0294577-6k_akanda.htm 6-K 8851
2 PRESS RELEASE DATED JUNE 12, 2026 ea029457701ex99-1.htm EX-99.1 6236
  Complete submission text file 0001213900-26-068010.txt   16155
Mailing Address 77 KING STREET WEST, SUITE 400 C/O DENTONS CANADA LLP TORONTO A6 M5K 0A1
Business Address 1A, 1B LEAROYD ROAD NEW ROMNEY X0 TN28 8XU 442034889514
AKANDA CORP. (Filer) CIK: 0001888014 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41324 | Film No.: 261084964
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)